Kidney-sparing Surgery Improves Survival in Study
Researchers have found that patients with early stage kidney cancer lived longer when only part of their kidney was removed, instead of the entire kidney.
Avastin Approved for Kidney Cancer
Avastin (bevacizumab), manufactured by Genentech, was recently approved to treat the most common type of kidney cancer.
FDA Greenlights New Drug for Advanced Kidney Cancer
The US Food and Drug Administration (FDA) has approved everolimus, made by Novartis and marketed as Afinitor, for the treatment of advanced kidney cancer, or renal cell carcinoma.